An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study

MacLaren, Robert E.; Audo, Isabelle; Fischer, M. Dominik; Huckfeldt, Rachel M.; Lam, Byron L.; Pennesi, Mark E.; Sisk, Robert; Gow, James A.; Li, Jiang; Zhu, Kan; Tsang, So-Fai

dc.contributor.author	Fischer, Manuel Dominik
dc.date.accessioned	2024-11-25T09:43:51Z
dc.date.available	2024-11-25T09:43:51Z
dc.date.issued	2024
dc.identifier.issn	1043-0342
dc.identifier.uri	http://hdl.handle.net/10900/159081
dc.language.iso	en	de_DE
dc.publisher	New Rochelle : Mary Ann Liebert, Inc	de_DE
dc.relation.uri	http://dx.doi.org/10.1089/hum.2024.017	de_DE
dc.subject.ddc	570	de_DE
dc.subject.ddc	610	de_DE
dc.title	An Open-Label Phase II Study Assessing the Safety of Bilateral, Sequential Administration of Retinal Gene Therapy in Participants with Choroideremia: The GEMINI Study	de_DE
dc.type	Article	de_DE
utue.quellen.id	20241001000000_00643
utue.publikation.seiten	564-575	de_DE
utue.personen.roh	MacLaren, Robert E.
utue.personen.roh	Audo, Isabelle
utue.personen.roh	Fischer, M. Dominik
utue.personen.roh	Huckfeldt, Rachel M.
utue.personen.roh	Lam, Byron L.
utue.personen.roh	Pennesi, Mark E.
utue.personen.roh	Sisk, Robert
utue.personen.roh	Gow, James A.
utue.personen.roh	Li, Jiang
utue.personen.roh	Zhu, Kan
utue.personen.roh	Tsang, So-Fai
dcterms.isPartOf.ZSTitelID	Human Gene Therapy	de_DE
dcterms.isPartOf.ZS-Issue	15-16	de_DE
dcterms.isPartOf.ZS-Volume	35	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE